The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)

BACKGROUND: It is frequently asked whether chemotherapy can still play a role in metastatic melanoma considering the effectiveness of the available drugs today, including antiCTLA4/antiPD1 immunotherapy and antiBRAF/antiMEK inhibitors. However, only approximately half of patients respond to these dr...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Cancer
Главные авторы: Guida, Michele, Tommasi, Stefania, Strippoli, Sabino, Natalicchio, Maria Iole, De Summa, Simona, Pinto, Rosamaria, Cramarossa, Antonio, Albano, Anna, Pisconti, Salvatore, Aieta, Michele, Ridolfi, Ruggiero, Azzariti, Amalia, Guida, Gabriella, Lorusso, Vito, Colucci, Giusepe
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946485/
https://ncbi.nlm.nih.gov/pubmed/29747595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4479-2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы